Navigation Links
Pain Killers To Carry Warnings About Heart Attack And Stroke Risk

Pain killers which are commonly used for a number of painful complaints, have been shown to increase the risk of heart attack and stroke//. This has lead to an order by the Commission on Human Medicines whereby these drugs will have to carry a warning along with the information put on them by the manufacturers.

Doctors are being informed of the small but increased risk in long term treatment with high doses of these drugs. These are used very commonly for conditions of chronic pain in osteoarthritis and rheumatoid arthritis, and are known as Non Steroidal Anti Inflammatory Drugs (NSAID).

Studies have shown that high doses(around 2400 mg) of these drugs increase the risk of heart attack, and an investigation into NSAIDs was launched last month by the European Medicines Agency.

Diclofenac, etodolac, ibuprofen, indomethacin, ketoprofen, ketorolac, meloxicam, nabumetone, naproxen, and nimesulide are the NSAIDS which have been reviewed. Low dose (400mg) ibuprofen which is an OTC drug is considered safe and will not have to include the cautionary information.

The director for vigilance and risk management, Medicines and Healthcare products Regulatory Agency, Dr. June Raine, said that the benefits of the drugs are still considered to outweigh the risks, and that it was not required that patients stop their medications if they felt well. However it is advisable to keep the treatment as low dose and short term as possible.
MAL
'"/>




Page: 1

Related medicine news :

1. Pain Killers Keep the Virus Away
2. Heart Related Problems-The Largest Killers In Andhra Pradesh
3. Cereal Killers: Is the Loaded Breakfast Bowl Really Healthy?
4. Copper Alloys Surfaces Touted As Pathogen Killers
5. Preventive Mastectomy Does Not Carry Emotional Baggage For Most Women
6. Well-Planned Surgeries Also Carry Health Risks
7. Cigarette Packets to Carry Skull-and-bones Sign
8. Apollo Group Permitted to Carry out Surgeries in its Oman Centre
9. Babies at Hospital found to Carry Super bug MRSA
10. Allergic Individuals Should Carry Two Doses Of EpiPen Says Quebec Coroner
11. Skin Lightening Products Carry Risk of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2016)... , ... May 06, 2016 , ... ... arrival of Sovaldi, which made headlines mostly for its cost despite its potential ... and moral questions surrounding the drug—part of a class called direct-acting antivirals (DAAs)—have ...
(Date:5/6/2016)... ... 2016 , ... RowdMap, Inc. co-founder, Joshua Rosenthal, PhD, joins ... Deputy Administrator at Centers for Medicare and Medicaid Services (CMS); Ali Khan, MD, ... Officer at Health Care Service Corporation (Blue Cross and Blue Shield of Illinois, ...
(Date:5/5/2016)... Texas (PRWEB) , ... May 05, 2016 , ... ... the Responsible Wool Standard (RWS) for public stakeholder review. The stakeholder review is an ... that it meets its goals and delivers value to the wool industry., The RWS ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... This weekend, from Friday, May 6 - ... on steep California terrain at the first Team Semper Fi Mountain Bike Camp, hosted in ... will be mountain bike legends Mark Weir and Jason Moeschler, who’ll share pro tips with ...
(Date:5/5/2016)... Indianapolis, IN (PRWEB) , ... May 05, 2016 ... ... employee benefits advisory organization, announces McLaughlin & Smoak Benefits as the latest addition ... & Smoak Benefits has a dedicated team of compliance, wellness, human resources, and ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of Jerusalem announced today that it had signed ... BioTheryX, Inc. , developer of novel protein degradation and ... development and commercialization of drug candidates representing first-in-class therapy ... license were not disclosed. The novel technology ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Myeloid Leukemia Market ... to their offering.       (Logo: ... Myeloid Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Myeloid Leukemia epidemiology, ...
(Date:5/3/2016)... 2016 Research and Markets has ... Cell Therapy Market Outlook 2020" report to their ... , ,Recombinant technology has improved significantly in past years ... developed in coming years. Many cancer drugs have been ... therapies are also expected to be developed with its ...
Breaking Medicine Technology: